Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to Eutropics Pharmaceuticals in September, 2017 for $2,989,986.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44CA203610-02A1 | Phase II | 2,989,986 | September 12, 2017 | |||||||
A SBIR Phase I contract was awarded to Eutropics Pharmaceuticals for $199,892.0 USD from the U.S. Department of Health & Human Services. | SBIR | N43CO120085 | Phase I | 199,892 | ||||||||
A SBIR Phase II contract was awarded to Eutropics Pharmaceuticals for $1,499,746.0 USD from the U.S. Department of Health & Human Services. | SBIR | N44CO120039 | Phase II | 1,499,746 | ||||||||
A SBIR Phase II contract was awarded to Eutropics Pharmaceuticals for $1,499,743.0 USD from the U.S. Department of Health & Human Services. | SBIR | N44PC140020 | Phase II | 1,499,743 | ||||||||
A SBIR Phase I contract was awarded to Eutropics Pharmaceuticals for $326,983.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA135915-01 | Phase I | 326,983 | ||||||||
A SBIR Phase II contract was awarded to Eutropics Pharmaceuticals for $1,357,720.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44CA135915-02A1 | Phase II | 1,357,720 | ||||||||
A SBIR Phase I contract was awarded to Eutropics Pharmaceuticals for $199,860.0 USD from the U.S. Department of Health & Human Services. | SBIR | N43CO201000134 | Phase I | 199,860 |